AbbVie Makes $63B Bid for Botox Maker Allergan - NBC10 Boston

AbbVie Makes $63B Bid for Botox Maker Allergan

Regulators and Allergan shareholders still need to approve the deal

Find NBC Boston in your area

Channel 10 on most providers

Channel 15, 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    AbbVie Makes $63B Bid for Botox Maker Allergan
    AP
    This March 20, 2002 file photo shows a vial of Botox, made by Allergan. (AP Photo/Damian Dovarganes)

    AbbVie is buying Botox maker Allergan in a cash-and-stock deal valued at about $63 billion.

    The maker of the blockbuster immune disorder treatment Humira said Tuesday that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. That amounts to $188.24 per share, or a 45% premium to Allergan's closing price Monday.

    Shares of Allergan Plc, based in Dublin, Ireland, jumped nearly 30% before the opening bell.

    AbbVie shareholders will own 83% of the specialty drug company combination after the deal's completion while Allergan shareholders will have a 17% stake.

    Air Force Major Charged With Wife's Gruesome Murder

    [NATL] Air Force Major Charged With Wife's Gruesome Murder
    The husband of a missing San Antonio, Texas, woman was charged with murder after authorities confirmed they'd found the remains 29-year-old Andreen McDonald. The Bexar County Sheriff's Office arrested Andre McDonald, 40, just two days after authorities found a human skull and bones Thursday night. 
     
    (Published Tuesday, July 16, 2019)

    Regulators and Allergan shareholders still have to approve the deal.

    Shares of AbbVie Inc., based in North Chicago, Illinois, sank 10%.